Diagnosis of hyperinsulinemia and type II diabetes and protection against same based on genes differentially expressed in muscle cells

Details for Australian Patent Application No. 2005216922 (hide)

Owner Ohio University Icoria, Inc.

Inventors Boyce, Keith S.; Kopchick, John J.; Coschigano, Karen T.; Kriete, Andres

Agent Griffith Hack

Pub. Number AU-A-2005216922

PCT Pub. Number WO2005/082398

Priority 60/579,342 15.06.04 US; 60/547,512 26.02.04 US

Filing date 24 February 2005

Wipo publication date 9 September 2005

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

7 September 2006 PCT application entered the National Phase

  PCT publication WO2005/082398 Priority application(s): WO2005/082398

20 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005216923-Compression treatment system

2005216914-X-spring volume compensator for automotive carbon canister